Autoimmune Epilepsy Evaluation Profile, Spinal Fluid
Also known as: Autoimmune Paraneoplastic Panel Spinal Fluid, Paraneoplastic
Use
This test is used for the detection of antineuronal autoantibodies that help in the diagnosis of paraneoplastic syndromes and autoimmune encephalopathies and related conditions.
Special Instructions
If reflex test is performed, additional charges/CPT code(s) may apply. This test has not been cleared or approved by the Food and Drug Administration, but it is developed in accordance with CLIA requirements.
Limitations
The performance characteristics of this test were determined by Labcorp in accordance with CLIA requirements. However, it has not been cleared or approved by the Food and Drug Administration, which may affect its interpretative use in some cases.
Methodology
Other
Biomarkers
LOINC Codes
- 94818-2
- 56850-1
- 44768-0
- 56959-0
- 90836-8
- 14247-1
- 90843-4
- 90845-9
- 90815-2
- 63216-6
- 90827-7
- 82989-5
- 93500-7
- 96481-7
- 90832-7
- 101229-3
- 90844-2
- 90811-1
- 93491-9
- 93426-5
- 82988-7
- 94711-9
- 90820-2
- 90830-1
Result Turnaround Time
4 days
Related Documents
For more information, please review the documents below
Specimen
Cerebrospinal Fluid
Volume
2 mL
Minimum Volume
1 mL
Container
Sterile plastic tube
Storage Instructions
Room temperature
Causes for Rejection
Gross hemolysis; grossly lipemic; gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 14 days |